In the present study, the infiltration of CD4+ T-cells into the myocardium of mice increased following the administration of a PD-1 inhibitor, suggesting that the modulation of CD4+ T-cells may provide a novel therapeutic direction for ICI-related myocarditis. The gene discussed is CD4; the disease is myocarditis.